The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Today, many thousands of consumers have filed lawsuits against hernia surgical mesh implant manufacturers. Big name pharmaceutical companies like C.R. Bard, Johnson & Johnson/Ethicon, Atrium and others are the focus in these lawsuits for the debilitating medical side effects that resulted from their hernia mesh products.

There are multiple serious risks associated with hernia mesh implants, which are used today in over 90 percent of the one million annual hernia repairs in the United States. Multiple medical complications can occur after implantation, such as organ perforation, nerve damage, infection, emotional and mental health issues, extreme levels of pain, and even death. The risk of hernia mesh implant complications increases over time after implantation.

The FDA has already issued recalls or voluntary market withdrawals for certain hernia mesh implants due to safety concerns. This includes, but is not limited to:

C-QuR Mesh (Atrium)
Physiomesh Flexible Composite Mesh (Ethicon/Johnson & Johnson)

Other hernia surgical mesh products have been associated with dangerous complications as well.

Ongoing litigation is expected to continue into 2019, with Ethicon/Johnson & Johnson, Covidien, Gore, Atrium and C. R. Bard all facing upcoming litigation and/or bellwether trials later this year. Previous hernia mesh trials and lawsuits have already resulted in major wins for plaintiffs as well, with some receiving large sums of compensation for their hardships and injuries.

Our law firm of Childers, Schlueter, & Smith is well-versed in drug and medical device litigation and might be able to help you or a family member who is suffering due to complications caused by a hernia mesh. If you have questions, please give us a call at 1-800-641-0098. All initial inquiries are free of charge and without obligation.

Join the Discussion

Your email address will not be published. Required fields are marked *

Of Interest